What is the appropriate treatment for screw‑worm (Cochliomyia) myiasis in humans and animals?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Screwworm (Cochliomyia hominivorax) Myiasis

For screwworm myiasis in both humans and animals, the most effective treatment is systemic ivermectin combined with manual larval removal, achieving 100% efficacy within 24 hours.

Primary Treatment Approach

Pharmacological Treatment

Ivermectin is the drug of choice for screwworm myiasis based on multiple recent studies demonstrating rapid larvicidal action:

  • Dosing: Administer ivermectin 200 μg/kg (micrograms per kilogram) as a single oral dose 1, 2, 3, 4
  • Efficacy: Achieves 100% larval death within 24 hours of administration 1, 5, 6
  • Onset: Larvae begin expelling within 2-6 hours post-treatment, with 80-93% expulsion by 6 hours 1

Mechanical Removal

At 24 hours post-treatment, perform complete wound debridement:

  • Manually remove all remaining dead larvae from the wound
  • Clean the wound thoroughly
  • Inspect carefully to ensure no larvae remain, as retained dead larvae can impede healing 5

Alternative Treatments (When Ivermectin Unavailable)

Isoxazoline Class Drugs (Veterinary Use)

For animals, newer isoxazoline compounds show excellent efficacy:

  • Lotilaner (Credelio™): 20.5 mg/kg orally, single dose - 100% efficacy at 24 hours 1
  • Afoxolaner (NexGard®): 2.5 mg/kg orally, single dose - 100% efficacy at 24 hours 6
  • Sarolaner: 2.7-3.7 mg/kg orally, single dose - 100% efficacy at 24 hours 5

Topical Adjunctive Treatment

10% creolin (phenol preparation) can be applied locally to control larvae while awaiting systemic drug action 4

Supportive Care Requirements

Antimicrobial Coverage

Administer antibiotics to prevent secondary bacterial infection:

  • Amoxicillin or ciprofloxacin are commonly used 2, 7
  • Screwworm wounds are frequently co-infected with Staphylococcus aureus and Pseudomonas aeruginosa 7

Wound Management

  • Provide analgesics for pain control 5
  • Clean wounds daily until complete healing
  • Monitor for signs of deeper tissue invasion or systemic infection

Critical Clinical Considerations

High-Risk Presentations

Umbilical myiasis in neonates requires urgent treatment due to risk of:

  • Larval migration to deeper abdominal tissues
  • Omphalitis
  • Sepsis and death 2

Anatomical Sites of Concern

Most commonly affected areas include 2:

  • Oral cavity
  • Open wounds (especially traumatic injuries)
  • Scalp
  • Natural orifices
  • Umbilical cord in neonates

Risk Factors to Identify

Patients at highest risk 2:

  • Extremes of age (neonates and elderly)
  • Poor hygiene conditions
  • Existing wounds or ulcers
  • Mental disability
  • Immunocompromised states

Treatment Timeline

Expected clinical course:

  • 0-2 hours: Initial larval expulsion begins
  • 2-6 hours: 80-93% of larvae expelled 1
  • 24 hours: 100% larval death achieved; perform complete wound cleaning
  • 12 days average: Hospital discharge for severe cases 4

Common Pitfalls to Avoid

  1. Do not rely solely on manual extraction - systemic treatment is essential as manual removal alone misses larvae deep in tissue
  2. Do not delay treatment - larvae are voracious and can cause life-threatening hemorrhage or tissue destruction
  3. Do not forget to remove dead larvae at 24 hours - retention of dead larvae (up to 34% with some treatments) impedes healing 5
  4. Do not overlook secondary bacterial infection - always provide antibiotic coverage

Public Health Implications

Screwworm myiasis is a notifiable disease with transboundary implications 8. Cases should be reported to veterinary and public health authorities, particularly in areas where eradication programs exist, as reintroduction can have major socioeconomic consequences 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.